Medical equipment supplier Becton Dickinson & Co (BDX.N) has agreed to buy CareFusion Corp (CFN.N), a maker of infusion pumps and other medical devices, for $12.2 billion in cash and stock, marking the latest multibillion-dollar healthcare sector deal.
Becton said on Sunday it would pay a total of $58.00 a share – $49.00 in cash and 0.0777 of a share of Becton Dickinson – for each share of CareFusion, representing a premium of 26 percent to the closing price on Oct. 3.
The US pharmaceutical company Baxter International is to establish a new global innovation and R&D center for biopharmacetucals in Cambridge, Massachusetts, US. This follows Baxter’s decision to hive off its biopharmaceutical business as an independent company called Baxalta in mid-2015.
The new R&D center will house 400 R&D staff, who will relocate from current sites in California and Europe, although Baxalta will retain certain R&D operations at its site in Vienna, Austria. In addition, the new center will house Baxalta’s business development, oncology and biosimilars teams.
Health officials are now monitoring 50 people in Texas for signs of Ebola, via twice-daily temperature checks, and in recent days, there have been reports that people in other areas of the country — most recently, Washington, D.C. — may be infected with the virus.
But why can’t all these people just be tested for Ebola as soon as possible?
DPOB’s new program, TechConnect, provides up to $10,000 per tech company (with at least 4 employees) for locating for at least one year within Downtown Baltimore. Partner perks, including discounted design, legal and internet service and free zipcar hours are available as well. DPOB will also help companies through site selection, mitigate any move/set up issues, distribution of permits, etc. and they have two partner brokers on board to provide full brokerage service. Read more about their new program here: http://www.godowntownbaltimore.com/work/TechConnect/index.aspx
Pipeline updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight into the commercial potential of the candidate once it is successfully developed and commercialized.
Roche (RHHBY – Analyst Report) specializes in cancer drugs. Immunotherapy has received a lot of attention in recent times as pharmaceuticals majors focus their research and development efforts on the same.
The three-story brick building at the corner of Main and Osborn streets in Cambridge, on the edge of Kendall Square and the MIT campus, captures three distinct eras in the city’s innovation history. In the early 1800s, it was the site of Kimball & Davenport, the first builder of passenger railroad cars in America.
After World War II, it was the epicenter of the Massachusetts tech boom, home to the office and private lab of Edwin Land, Polaroid’s founder. In between, Thomas A. Watson strung a wire from Boston to Cambridge, and set up the equipment to receive the first “long distance” phone call, in 1876.
Lecture 1: The Importance of Commercializing Research Tuesday, October 7, 2014, 1:00 to 2:30 pm ET
Now on its seventh run, the Research Commercialization Introductory Course is a very popular online course designed to help science and engineering researchers better understand how research commercialization works. Over 5000 students, faculty and researchers from across the US have taken this course since it’s been offered.
Research commercialization involves taking articles, documentation, know-how, patents, and copyrights, which are created during research activities and getting them to users and patients for real societal impacts. In some cases, commercialization involved taking patents based on the research and licensing them to a company. This usually involves also having the researchers consult to the company. In other cases, commercialization involves forming of creating a startup and applying to federally funded commercialization programs. In all cases, though, research commercialization typically involves defining the nature of the research being commercialized (e.g., in a patent or intellectual property agreement), establishing a commercial relationship with another party (e.g., employment, a sale or license), and negotiating a contract (e.g., compensation).
Areas covered in the course include intellectual property, patents, copyrights, trade secrets, trademarks, licensing agreements, employment agreements, consulting agreements, tech transfer, creating and funding companies, and federally funded Small Business Innovation Research (SBIR) programs
Each lecture is a live 90-minute online class with Q&A.
Tasly Pharmaceuticals, Inc. made its official debut at the Natural Products Expo East 2014, held from September 17-20, 2014 in Baltimore, MD. As the leading East Cost trade show in the natural, healthy and organic products industry, attracting 22,000 professionals and representing 33% of the natural products industry, Expo East 2014 was a perfect opportunity for Tasly to introduce Deepure, its inaugural line of nutraceuticals. The line includes three condition-specific, whole-food and herb-based formulas, namely, ProHeart PLUS, ImmunoPower PLUS, and Re-Memory PLUS. All Deepure nutraceuticals are gluten-free and made without chemicals, preservatives, artificial colors, flavors, sweeteners, or gelatin. Deepure will be available in stores nationwide later this Fall.
Tasly also participated in two very attractive marketing and sponsorship opportunities located in New Products Pavilion, including Best of East Press Showcase and New Products Showcase.
The U.S. Commerce Department’s National Institute of Standards and Technology (NIST) has selected The MITRE Corporation to operate the first federally funded research and development center (FFRDC) solely dedicated to enhancing cybersecurity and protecting national information systems. MITRE will partner with the University System of Maryland (USM) to support the center.
The new FFRDC will support the National Cybersecurity Center of Excellence (NCCoE), which NIST, the state of Maryland, and Montgomery County, Md., established in 2012 to help businesses secure their data and digital infrastructure by bringing together information security experts from industry, government and academia. MITRE will further the NCCoE’s goal to foster public-private collaborations to identify and solve today’s most pressing cybersecurity challenges. Working with the University of Maryland, College Park (UMCP) and the University of Maryland, Baltimore County (UMBC), two leading research institutions within the USM, MITRE will carry out the goals of the new FFRDC in research, development, engineering and technical support as well as operations and facilities planning.
In the U.S., North America, and around the Globe, education innovation clusters are popping up across the landscape to solve the 21st century’s toughest learning challenges. Some of these economic development clusters, moreover entrepreneurship hubs, will lead in ways that others cannot. Maryland is one of them.
